Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B BRODIE

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Biochemistry|September 30, 1998
Lys75 of Anabaena ferredoxin-NADP+ reductase is a critical residue for binding ferredoxin and flavodoxin during electron transferM Martínez-Júlvez, M Medina, J K Hurley, et al.
The Pediatric Infectious Disease Journal|January 22, 2000
Occurrence of nosocomial bloodstream infections in six neonatal intensive care unitsS B Brodie, K E Sands, J E Gray, et al.
Journal of the American College of Cardiology|September 1, 1995
Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registryD B Mark, W W O'Neill, B Brodie, et al.
The Journal of Invasive Cardiology|March 24, 2000
Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first"D J Kereiakes, E Fry, W Matthai, et al.
Biochemistry|February 20, 2003
Role of hydrophobic interactions in the flavodoxin mediated electron transfer from photosystem I to ferredoxin-NADP+ reductase in Anabaena PCC 7119Isabel Nogués, Marta Martínez-Júlvez, José A Navarro, et al.
The Journal of Biological Chemistry|May 9, 2001
Role of a cluster of hydrophobic residues near the FAD cofactor in Anabaena PCC 7119 ferredoxin-NADP+ reductase for optimal complex formation and electron transfer to ferredoxinM Martínez-Júlvez, I Nogués, M Faro, et al.
The Journal of Invasive Cardiology|April 5, 2001
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary interventionD J Kereiakes, C Grines, E Fry, et al.
Journal of the American College of Cardiology|April 30, 1998
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial InfarctionC L Grines, D L Marsalese, B Brodie, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Biochemistry|September 30, 1998
Lys75 of Anabaena ferredoxin-NADP+ reductase is a critical residue for binding ferredoxin and flavodoxin during electron transferM Martínez-Júlvez, M Medina, J K Hurley, et al.
The Pediatric Infectious Disease Journal|January 22, 2000
Occurrence of nosocomial bloodstream infections in six neonatal intensive care unitsS B Brodie, K E Sands, J E Gray, et al.
Journal of the American College of Cardiology|September 1, 1995
Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registryD B Mark, W W O'Neill, B Brodie, et al.
The Journal of Invasive Cardiology|March 24, 2000
Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first"D J Kereiakes, E Fry, W Matthai, et al.
Biochemistry|February 20, 2003
Role of hydrophobic interactions in the flavodoxin mediated electron transfer from photosystem I to ferredoxin-NADP+ reductase in Anabaena PCC 7119Isabel Nogués, Marta Martínez-Júlvez, José A Navarro, et al.
The Journal of Biological Chemistry|May 9, 2001
Role of a cluster of hydrophobic residues near the FAD cofactor in Anabaena PCC 7119 ferredoxin-NADP+ reductase for optimal complex formation and electron transfer to ferredoxinM Martínez-Júlvez, I Nogués, M Faro, et al.
The Journal of Invasive Cardiology|April 5, 2001
Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary interventionD J Kereiakes, C Grines, E Fry, et al.
Journal of the American College of Cardiology|April 30, 1998
Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary Angioplasty in Myocardial InfarctionC L Grines, D L Marsalese, B Brodie, et al.
Pageof 7